Skip to content

Patients With Acute Renal Failure During Severe COVID-19

Renal Assessment of Patients With Acute Renal Failure During Severe COVID-19

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05077163
Acronym
IR-EST-POSTCOV
Enrollment
40
Registered
2021-10-14
Start date
2020-12-01
Completion date
2021-12-31
Last updated
2021-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Failure Chronic

Keywords

COVID-19, SARS-COV-2, Renal failure

Brief summary

The occurrence of renal failure during severe forms of COVID-19 is common (20-35% of patients treated in intensive care) and associated with an unfavorable short-term prognosis, but the medium-term renal outcome is not is not known. The aim of the study is to establish the frequency of chronic kidney failure after AKI KDIGO 2 and 3 occurring during severe COVID-19 in intensive care.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Major subject (≥18 years old) * Subject hospitalized in an intensive care unit, Strasbourg, Nancy or Reims hospitals, for severe COVID-19 between February 1, 2020 and July 31, 2020. * Having presented acute renal failure KDIGO 2 (assessed on a doubling of serum creatinine compared to the patient's reference values) or 3 (serum creatinine greater than 3 times the patient's reference, or anuria, or any recourse to extra-purification renal) * Having left hospital alive after initial treatment for COVID-19 * Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria

* Subject having expressed opposition to participating in the study * Subject under guardianship or guardianship * Subject under safeguard of justice

Design outcomes

Primary

MeasureTime frame
Retrospective study of renal development in patients with acute renal failure during severe COVID-19Files analysed retrospectively from February 01, 2020 to July 31, 2020 will be examined]

Countries

France

Contacts

Primary ContactBruno MOULIN, MD, PhD
Bruno.Moulin@chru-strasbourg.fr33 3 69 55 05 11
Backup ContactSaïd CHAYER, PhD, HDR
said.chayer@chru-strasbourg.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026